As with all laxatives, Dulcolax should not be used on a continuous daily basis for more than five days without investigating the cause of constipation.

Long-term everyday use of stimulant laxatives may harm the intestinal function and should be avoided. If laxatives are needed every day the cause of the constipation should be investigated. This product should only be used if a therapeutic effect cannot be achieved by a change of diet or the administration of bulk forming agents.

Prolonged excessive use may lead to fluid and electrolyte imbalance and hypokalaemia.

Intestinal loss of fluids can promote dehydration. Symptoms may include thirst and oliguria. In patients suffering from fluid loss where dehydration may be harmful (e.g. renal insufficiency, elderly patients) Dulcolax should be discontinued and only be restarted under medical supervision.

Stimulant laxatives (including Dulcolax) do not help with weight loss.

Patients may experience haematochezia (blood in stool) that is generally mild and self-limiting.

If the symptoms worsen during the use of the medicinal product, a doctor or

Pharmacist should be consulted.

Produkt przechowywać w sposób niedostępny dla dzieci, w temperaturze pokojowej. Zaleca się chronić przed działaniem wilgoci i światła. Nie powinno się stosować leku równocześnie z innymi środkami przeczyszczającymi (zwiększa się ryzyko działań niepożądanych ze strony żołądka i jelit). Możliwość stosowania leku u kobiet w ciąży i karmienia piersią należy skonsultować z lekarzem, przy czym zaleca się stosować lek wyłącznie w sytuacjach, gdy jest to bezwzględnie konieczne. Lek nadaje się do stosowania w okresie karmienia piersią.

Do not store above 25°C

In order to protect from light, keep the blister in the outer carton.

Dizziness and / or syncope have been reported in patients who have taken Dulcolax. The details available for these cases suggest that the events would be consistent with defaecation syncope (or syncope attributable to straining at stool), or with a vasovagal response to abdominal pain related to the constipation, and not necessarily to the administration of bisacodyl itself.

There have been isolated reports of abdominal pain and bloody diarrhoea occurring after taking bisacodyl. Some cases have been shown to be associated with colonic mucosal ischaemia.

The use of suppositories may lead to painful sensations and local irritation, especially in patients with anal fissures and ulcerative proctitis.